Several research firms recently issued reports on HYH. JMP Securities cut Halyard Health from an “outperform” rating to a “market perform” rating and set a $38.00 price target on the stock. in a report on Friday, January 6th. Zacks Investment Research cut Halyard Health from a “buy” rating to a “hold” rating in a report on Thursday, January 5th. Finally, Deutsche Bank AG cut Halyard Health from a “buy” rating to a “hold” rating and set a $35.00 price target on the stock. in a report on Thursday, December 15th.
Halyard Health, Inc. (NYSE:HYH) has been assigned an average recommendation of “Hold” from the six analysts that are currently covering the stock. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $37.00.
Institutional investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its position in Halyard Health by 704.7% in the third quarter. JPMorgan Chase & Co. now owns 608,265 shares of the company’s stock valued at $21,082,000 after buying an additional 532,677 shares during the last quarter. Panagora Asset Management Inc. raised its stake in Halyard Health by 103.2% in the third quarter. Panagora Asset Management Inc. now owns 770,426 shares of the company’s stock worth $26,703,000 after buying an additional 391,232 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Halyard Health by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,210,051 shares of the company’s stock worth $81,729,000 after buying an additional 330,186 shares in the last quarter. Cove Street Capital LLC raised its stake in Halyard Health by 60.7% in the second quarter. Cove Street Capital LLC now owns 816,808 shares of the company’s stock worth $26,563,000 after buying an additional 308,600 shares in the last quarter. Finally, Hancock Holding Co. acquired a new stake in Halyard Health during the third quarter worth approximately $7,365,000. 87.50% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Halyard Health (NYSE:HYH) opened at 40.14 on Wednesday. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 42.75 and a beta of 1.87. The stock’s 50 day moving average is $38.24 and its 200-day moving average is $36.15. Halyard Health has a 1-year low of $22.91 and a 1-year high of $40.40.
Halyard Health Company Profile
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.